Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2017

Mar 2, 2017

29777_dirs_2017-03-02_66b00c4a-cb21-43fd-a2b3-a77650eea117.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-02-28

Reporting Person: Funck Robert E (Vice President, Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-28 Common shares without par value F 3742 $45.46 Disposed 88337 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 16654 Indirect
Common shares without par value 500 Indirect
Common shares without par value 500 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2017.

F2: The reporting person disclaims beneficial ownership of all securities held by his daughter.